key: cord-0898860-2ml1pjhz
authors: Franco-Paredes, Carlos; Suarez, Jose Antonio; Henao-Martínez, Andrés F.
title: Correspondence Global COVID-19 Vaccine Equity Should Precede Requiring Travelers Proof of Vaccination
date: 2021-02-26
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.02.061
sha: 2c0b10623e481ecb21d852a2cbf3d1e0c37d31b5
doc_id: 898860
cord_uid: 2ml1pjhz

nan

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

prophylaxis using the International Certificate of Vaccination or Prophylaxis (ICVP) is required for travelers to cross international borders. 2 This practice seeks to protect travelers from acquiring the infection during their travel or introducing yellow fever by infected travelers into a nation. 1 The recent editorial by Petersen et al recommends the inclusion of proof of COVID-19 vaccination in the ICVP under the IHR 3 . We feel that this recommendation may exacerbate global COVID-19 vaccine inequities during this pandemic.

Adequate levels of vaccinations against routine vaccine-preventable diseases have dropped substantially during this pandemic [4] [5] . Focusing on ensuring the COVID-19 vaccination of travelers -a privileged population in high-income countries-is hard to justify from a health equity perspective. While the IHR has no role to play in terms of global health equity, the preferential deployment of pandemic vaccines to high-income countries at this point during the pandemic promotes further vaccine inequity. Furthermore, achieving adequate COVID-19 vaccination coverage and allocation among low-income and middle-income countries (LMIC) is an ongoing challenge. [6] [7] We feel that requiring proof-of-COVID-19 vaccination for crossing borders will selectively protect the group of travelers from high-income countries, where COVID-19 vaccines are available. Travelers from LMIC have no access to COVID-19 vaccines and since currently available vaccines require at least two vaccination doses over a 21 period to achieve adequate protection, vaccination at the time of entry into a country with the availability of COVID-19 vaccines is unfeasible.

This editorial also fails to address the growing literature that demonstrates the protective longterm humoral and cellular immunity among the majority of individuals with previous COVID-19 infection. [8] [9] Proof of immunity is thus highly relevant when considering immunization policies in 

The International Health Regulations (2005), the threat of populism and the COVID-19 pandemic

Prevention of yellow fever in travellers: an update

COVID-19 vaccines under the International Health Regulations -we must use the WHO International Certificate of Vaccination or Prophylaxis

COVID-19 and routine childhood immunization in Africa: Leveraging systems thinking and implementation science to improve immunization system performance

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access

Equitable global access to coronavirus disease 2019 vaccines

Evolution of antibody immunity to SARS-CoV-2

Beigel JH; mRNA-1273 Study Group. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

International travel between global urban centres vulnerable to yellow fever transmission